Tag Archives: bioMérieux

bioMérieux Opens a Molecular and Genomic Innovation Center at the Navy Yard in Philadelphia

By Food Safety Tech Staff
No Comments

bioMérieux selected to open the site at the Navy Yard, which serves the region as an innovation Life Sciences hub focused on research and development, commercialization and manufacturing, and boasts a roster of regional and global companies currently occupying more than one-million square feet of life sciences and advanced manufacturing space.

The new 32,000 sq. ft. facility is home to the xPRO™ Program, which has rapidly changed the landscape of food safety diagnostic capabilities by partnering directly with industry leaders to address unmet needs to streamline operational efficiencies and further public health. bioMérieux’s global leadership team was on-site for the ribbon cutting event, as Philadelphia continues to fortify its reputation as a hotbed of innovation in Life Sciences across North America.

Global leadership from bioMérieux and Philadelphia dignitaries commemorate the opening of the company’s Molecular Genomic Innovation Center in Philadelphia, Wednesday, Sept. 18, 2024. (Ryan Collerd/AP Content Services for bioMérieux)

“We couldn’t be more excited to deepen our roots in Philadelphia, which has long supported our organization through its commitment to fostering an entrepreneurial environment that promotes innovation and collaboration,” said Ben Pascal, global head of the xPRO™ Program, “As the innovation leader in the market and with our focus on maintaining a culture of entrepreneurship, the new site bolsters our ability to rapidly respond and develop breakthrough innovations that change the paradigm for global food safety.”

bioMérieux selected to open the site at the Navy Yard, which serves the region as an innovation Life Sciences hub focused on research and development, commercialization and manufacturing, and boasts a roster of regional and global companies currently occupying more than one-million square feet of life sciences and advanced manufacturing space. The opening of bioMérieux at the Navy Yard strengthens the sites reputation as a foremost innovation hub across the US.

“The opening of the Molecular and Genomic Innovation Center at the Navy Yard is an important milestone in bioMérieux’s storied legacy, as we continue to provide game changing diagnostic solutions that solve the food safety industry’s most persistent and urgent challenges,” said Miguel Villa, Sr. Vice President, Industrial Applications, Americas, and xPRO™ sponsor, “This facility – in conjunction with our unique Augmented Diagnostics approach to food safety – allows us to continue redefining the role and capabilities of diagnostic testing to further ensure public health and fortify brand reputations.” 

Food Safety Tech Content Director, Rick Biros tours bioMérieux’s Molecular Genomic Innovation Center in Philadelphia. (Ryan Collerd/AP Content Services for bioMérieux)

 

USDA Awards bioMérieux’s GENE-UP® Pathogenic E. coli (PEC) as Method of Choice for Shiga Toxin-Producing E. coli (STEC) Detection in USDA-FSIS Laboratories

By Food Safety Tech Staff
No Comments

According to the June 28, 2024 USDA Constituent Update, FSIS evaluated commercially available pathogen screening technologies and will adopt a new rapid screening test for adulterant Shiga toxin-producing E. coli (STEC). Specifically, FSIS will use the bioMérieux GENE-UP® Pathogenic E. coli (PEC) platform to screen enriched samples received on or after September 16, 2024, for adulterant STEC. This screening method adds efficiency by employing a novel molecular diagnostic target to rapidly identify samples containing STEC. FSIS expects that adoption of this new screening method will reduce the number of potential–and presumptive–positive STEC results that do not confirm positive with our current method. FSIS expects that industry will see reduced product holding times while waiting for laboratory results.

USDA Logo

USDA Awards bioMérieux GENE-UP® CAMPLYLOBACTER as Method of Choice for Campylobacter Detection

By Food Safety Tech Staff
No Comments
USDA Logo

USDA announced that the agency has awarded bioMérieux’s Gene-Up® Campylobacter as the method of
choice for Campylobacter Detection in USDA FSIS Labs. GENE-UP® CAMPYLOBACTER is a real-time PCR-based solution that delivers results in under an hour and is AOAC validated for a variety of enrichment medias.

“We are thrilled to be awarded this contract by the USDA-FSIS. With the inclusion of GENE-UP® CAMPYLOBACTER, bioMérieux now has the most FSIS methods of choice for microbiology than any other diagnostics provider,” says Miguel Villa, Sr. Vice President, Americas, Industrial Applications, at bioMérieux. “This is a testament to our continued dedication to providing innovation within the animal protein sector and the food industry at large, reinforcing GENE-UP® as the full solution for all molecular testing needs in one place.”

The GENE-UP® CAMPYLOBACTER assay is the latest of bioMérieux’s molecular diagnostic solutions to be recognized by food safety regulatory bodies in the United States. Earlier this year, bioMérieux announced a research collaboration to improve microbial detection of food-borne pathogens with the Food and Drug Administration, and in 2022,
the USDA named bioMérieux’s GENE-UP® QUANT Salmonella quantification method of choice in all FSIS laboratories, with both GENE-UP® QUANT Salmonella and TEMPO® solutions currently included in the USDA Microbiology Laboratory Guidebook (MLG).

“Our Augmented Diagnostics approach helps food industry leaders go beyond the test results and harness data, genomics, and diagnostic insights to solve the toughest problems,” says John Shultz, Sr. Director, Sales and Marketing, Industrial Applications, at bioMérieux. “The recognition of GENE-UP® CAMPYLOBACTER as the method of choice of the USDA is yet another way that bioMérieux helps facilitate and advance the science of food safety and protect public health.”